AI in Drug Development 2026: The Shift to Execution

Webinar Date: Thursday, April 9th
Time: 12 pm ET | 9 am PT | 5 pm BST

In this live webinar, Sara Mallatt, AlphaSense’s Director of Healthcare Research and Dr. Paul Agapow, former Director of Data Science at GSK, will explore how AI is transforming medicine. As the first wave of AI-designed drugs move into advanced clinical trials, they will discuss whether AI is on track to make drug development faster, cheaper, and more successful.

Sara and Paul will discuss:

• The "Autonomous Lab" Shift: How robotics and AI are closing the loop in R&D.
• Regulatory Evolution: Navigating the new global rules for AI-assisted approvals.
• The Major Strategic Moves: How dealmaking is redefining the competition between pharma giants and the new wave of "TechBios.”